Colinz Laboratories Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Colinz Laboratories Ltd is ₹ 50 as of 05 May 15:30 . The P/E Ratio of Colinz Laboratories Ltd changed from 12.9 on March 2021 to 36.8 on March 2025 . This represents a CAGR of 23.33% over 5 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Colinz Laboratories Ltd changed from ₹ 3.47 crore on March 2021 to ₹ 33.11 crore on March 2025 . This represents a CAGR of 57.01% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 years The revenue of Colinz Laboratories Ltd for the Mar '26 is ₹ 1.92 crore as compare to the Dec '25 revenue of ₹ 1.51 crore. This represent the growth of 27.15% The revenue of Oxygenta Pharmaceutical Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 33.93 crore. This represent the decline of -100% The ebitda of Colinz Laboratories Ltd for the Mar '26 is ₹ 0.27 crore as compare to the Dec '25 ebitda of ₹ 0.18 crore. This represent the growth of 50% The ebitda of Oxygenta Pharmaceutical Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -4.08 crore. This represent the decline of -100% The net profit of Colinz Laboratories Ltd changed from ₹ 0.14 crore to ₹ 0.17 crore over 8 quarters. This represents a CAGR of 10.19% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Colinz Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Colinz Laboratories Ltd

Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986.
The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995.
The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc.
The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation. Apart from this, the Company has a WHO compliant plant at Sinnar.

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

FAQs for the comparison of Colinz Laboratories Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Colinz Laboratories Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Colinz Laboratories Ltd is 6 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 204 Cr

What are the key factors driving the stock performance of Colinz Laboratories Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Colinz Laboratories Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Colinz Laboratories Ltd and Oxygenta Pharmaceutical Ltd?

As of May 5, 2026, the Colinz Laboratories Ltd stock price is INR ₹50.0. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹55.21.

How do dividend payouts of Colinz Laboratories Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Colinz Laboratories Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.